RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

52 hedge funds and large institutions have $125M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
25
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Texas
$5.46M
2
LFWA
LBJ Family Wealth Advisors
Texas
$1.97M
3
EA
Emerald Advisers
Pennsylvania
$7.14M
4
Millennium Management
Millennium Management
New York
$951K
5
BIT
BlackRock Institutional Trust
California
$2.83M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$3.69M
2
Goldman Sachs
Goldman Sachs
New York
$0
3
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$497K
4
ACM
Ativo Capital Management
Illinois
$1.09M
5
TCIM
TIAA CREF Investment Management
New York
$369K
Name Holding Trade Value Shares
Change 		Shares
Change %
BlackRock
51
BlackRock
New York
$5K – – –
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$1K +$1K +41 New
Goldman Sachs
53
Goldman Sachs
New York
– -$225K -8,542 Closed
1 2
3